Showing 13–14 of 14 results

Lucentis (Ranibizumab), 1

2,021.22
Pharmacological action - inhibitory angiogenesis.

Naclof, eye drops, (1 mg / ml), 5

0.00
Postoperative inflammation after cataract surgery and other surgical procedures.